Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia  Anja Hviid Simonsen, Sanna-Kaisa Herukka, Niels Andreasen, Ines Baldeiras,

Slides:



Advertisements
Similar presentations
The PredictAD project: development of novel biomarkers and analysis software for early diagnosis of the Alzheimer's disease by Kari Antila, Jyrki Lötjönen,
Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Sleep disruption changes across the disease trajectory: Pilot findings from the healthy patterns sleep study Nancy A. Hodgson, Albert J. Safi Alzheimer's.
2002 Air Medical Transport Industry Awards Air Medical Journal Volume 22, Issue 2, Pages (March 2003) DOI: /S X(03) Copyright.
Application of Ultrasound and Ultrasound-Guided Intervention for Evaluating Elbow Joint Pathologies Chia-Wei Lin, Yan-Hao Chen, Wen-Shiang Chen Journal.
Extended Compression Ultrasound Performed by Emergency Physicians: A Modified Compression Ultrasound Examination to Detect Superficial and Deep Lower Limb.
DIAGNOSTIC ACCURACY AND CONFIDENCE IN THE CLINICAL DETECTION OF COGNITIVE IMPAIRMENT IN EARLY-STAGE PARKINSON’S DISEASE  Kathryn A. Wyman-Chick, Phillip.
Volume 3, Issue 4, Pages (November 2017)
Relationship between Microstructural Degeneration of the Corpus Callosum, White Matter Hyperintensities, and Motor Function in Cognitively Intact Elderly 
Hilkka Liedes, Jyrki Lötjönen, Gerald P. Novak, Mark Forrest Gordon 
Volume 15, Issue 7, Pages (June 2016)
Volume 3, Issue 1, Pages 1-9 (January 2017)
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease  Azadeh Karami, Helga Eyjolfsdottir, Swetha.
A SYSTEMATIC REVIEW AND META-ANALYSIS COMPARING QUALITY-OF-LIFE RATINGS FROM FAMILY AND PAID CAREGIVERS OF PEOPLE WITH DEMENTIA RESIDING IN CARE HOMES 
Flora H. Duits, Niels D. Prins, Afina W. Lemstra, Yolande A. L
Cerebrospinal fluid biomarkers for Alzheimer's disease are associated with neuropathology in cortical brain biopsy  Toni Seppälä, Ossi Nerg, Anne Koivisto,
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Nathalie I. R. Hugenholtz, Judith K. Sluiter, Frank J. H
Trajectory of multi-dimensional caregiving burden in chinese informal caregivers for dementia: Evidence from exploratory and confirmatory factor analysis.
INCREASED CSF LEVELS OF BIOMARKERS FOR NEURODEGENERATION IN FTLD-GRN MUTATION CARRIERS  Joery Goossens, Sara Van Mossevelde, Tobi Van den Bossche, Anne.
SERUM NEUROFILAMENT LIGHT PROTEIN PREDICTS CLINICAL OUTCOME IN TRAUMATIC BRAIN INJURY  Pashtun Shahim, Magnus Gren, Victor Liman, Ulf Andreasson, Niklas.
Localization of Hippocampal atrophy in Alzheimer's disease
Volume 3, Issue 2, Pages (June 2017)
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints  Argonde C. van Harten, Pieter Jelle Visser,
Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire  Roos J.
Christine Bredfeldt, Kristen Rice, Lisa Alecxih 
Volume 5, Pages (December 2016)
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
KETOGENIC DIET EFFECTS ON BRAIN KETONE METABOLISM AND ALZHEIMER'S DISEASE CSF BIOMARKERS  Suzanne Craft, Bryan J. Neth, Akiva Mintz, Kiran Sai, Nora Shively,
Alzheimer's disease biomarker-based clusters predict amyloid accumulation and cognitive decline in a preclinical cohort: Findings from the wisconsin registry.
Application of Resource Utilization in Dementia (RUD) instrument in a global setting  Anders Wimo, Anders Gustavsson, Linus Jönsson, Bengt Winblad, Ming-Ann.
Alzheimer’s disease core biomarkers and prediction of dementia in MCI: The effect of age at onset  Anna Caroli, Samantha Galluzzi, Clarissa Ferrari, Annapaola.
The global prevalence of dementia: A systematic review and metaanalysis  Martin Prince, Renata Bryce, Emiliano Albanese, Anders Wimo, Wagner Ribeiro, Cleusa.
DETECTING COGNITIVE DISORDERS USING THE MUISTIKKO WEB-BASED COGNITIVE TEST BATTERY: VALIDATION IN THREE COHORTS  Teemu Paajanen, Shadi Mahdiani, Marie.
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment  Sanna-Kaisa Herukka,
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Japanese brain bank network for neuroscience research
Diagnosis of irritable bowel syndrome
Why is the surgical high-risk patient still at risk?
Surgical Treatment for Octogenarians with Lung Cancer: Results from a Population- Based Series of 124 Patients  Hes A.P. Brokx, MD, Otto Visser, MD, PhD,
Ara S. Khachaturian, David P
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study  Kumar B. Rajan, Jennifer Weuve,
Infected aneurysm of the thoracic aorta
Application of Resource Utilization in Dementia (RUD) instrument in a global setting  Anders Wimo, Anders Gustavsson, Linus Jönsson, Bengt Winblad, Ming-Ann.
T Emerick, D Metro, R Patel, T Sakai  British Journal of Anaesthesia 
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study  Kumar B. Rajan, Jennifer Weuve,
Reviewer Acknowledgment
LIFESPAN OF ONE FOCUSED ULTRASOUND MEDIATED BLOOD-BRAIN BARRIER TREATMENT IN A MOUSE MODEL OF ALZHEIMER'S DISEASE  Charissa Poon, Kullervo Hynynen  Alzheimer's.
Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective  Matthew Baumgart, Heather M. Snyder,
Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision.
A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42  Kristel Sleegers,
Introduction: Evolution of military and veterans brain health research
Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer’s Disease  Nina Kokkonen, Sanna-Kaisa.
Sulantha S. Mathotaarachchi, Tharick A
The incremental diagnostic value of 18F-florbetapir imaging in naturalistic patients with cognitive impairment: The India-FBP study  Marina Boccardi,
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Linus Jönsson, Pei-Jung Lin, Ara S. Khachaturian 
Added value of 11C-PiB-PET imaging in the diagnosis of Alzheimer's disease  Kristian Frederiksen, Anne-Mette Hejl, Ian Law, Steen Hasselbalch, Gunhild.
Mark D. Meadowcroft, Douglas G. Peters, Carson J
Amygdalar local structural differences in early- and late-onset Alzheimer's patients  Enrica Cavedo, Michela Pievani, Marina Boccardi, Samantha Galluzzi,
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
DIFFERENCES IN ANALYTICAL SELECTIVITY OF β-AMYLOID (1-42) IMMUNOASSAYS EXPLAIN DISCORDANT RESULTS IN STUDY COMPARISONS  Hugo Marcel Vanderstichele, Emeric.
Alzheimer's Association towards Guidelines for Dementia Care Practice: Recommendations with emphasis on high-quality, person-centered care in long-term.
Regional anaesthesia to improve pain outcomes in paediatric surgical patients: a qualitative systematic review of randomized controlled trials  S. Suresh,
Volume 4, Issue 3, Pages (March 2018)
Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years  Kevin A. Matthews,
BRAIN AMYLOIDOSIS AND COGNITIVE DECLINE IN MCI: 12-MONTH FOLLOW-UP
Increased risk for dementia both before and after stroke: A population-based study in women followed over 44 years  Xinxin Guo, Svante Östling, Silke.
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER.
Presentation transcript:

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia  Anja Hviid Simonsen, Sanna-Kaisa Herukka, Niels Andreasen, Ines Baldeiras, Maria Bjerke, Kaj Blennow, Sebastiaan Engelborghs, Giovanni B. Frisoni, Tomasz Gabryelewicz, Samantha Galluzzi, Ron Handels, Milica G. Kramberger, Agnieszka Kulczyńska, Jose Luis Molinuevo, Barbara Mroczko, Agneta Nordberg, Catarina Resende Oliveira, Markus Otto, Juha O. Rinne, Uroš Rot, Esen Saka, Hilkka Soininen, Hanne Struyfs, Silvia Suardi, Pieter Jelle Visser, Bengt Winblad, Henrik Zetterberg, Gunhild Waldemar  Alzheimer's & Dementia: The Journal of the Alzheimer's Association  Volume 13, Issue 3, Pages 274-284 (March 2017) DOI: 10.1016/j.jalz.2016.09.008 Copyright © 2016 The Authors Terms and Conditions

Fig. 1 Modified stepwise Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach for the production of recommendations. PICO, population, diagnostic strategy or intervention, comparison strategy, and patient outcomes. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2017 13, 274-284DOI: (10.1016/j.jalz.2016.09.008) Copyright © 2016 The Authors Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.